HLA-DRB1 was previously reported by GWAS to be associated with asthma (19), rheumatoid arthritis (20) and systemic lupus erythematosus (21), implying its potential role in immune system modulation and it could thus be a candidate modifier of the disease. This evidence concerns the gene HLA-DRB1 and asthma.